KRABEVA 400MG

Product Description

KRABEVA 400MG INJECTION contains Bevacizumab which belongs to the group of medicines called Antineoplastic agents. It is used in adult patients with Fluoropyrimidine (chemotherapy medicine) to treat metastatic cancer in large bowel (colon or rectum).  It is also used with Paclitaxel/ Capecitabine (chemotherapy medicine) to treat metastatic breast cancer in adult patients.\n\nKRABEVA 400MG INJECTION is used with chemotherapy regimen containing Platinum to treat advanced non-small cell lung cancer without epidermal growth factor receptor (mutated protein responsible to cause cancer in a cell) and with Erlotinib (chemotherapy medicine) to treat metastatic non-small cell lung cancer with epidermal growth factor receptor (in cancer cells) in adult patients